Showing results (11-20 of 1,401) with videos related to
Sort By:
Pageof 141
Antimicrobial Agents and Chemotherapy|July 1, 1985
Directed biosynthesis of new saframycin derivatives with resting cells of Streptomyces lavendulaeT Arai, K Yazawa, K Takahashi, et al.The Japanese Journal of Antibiotics|November 1, 1989
[In vitro susceptibility of pathogenic Nocardia to beta-lactam antibiotics, especially imipenem, a carbapenem antibiotic]K Yazawa, Y Mikami, K Otozai, et al.Antimicrobial Agents and Chemotherapy|August 1, 1977
Morphological changes in yeasts as a result of the action of 5-fluorocytosineT Arai, Y Mikami, K Yokoyama, et al.Journal of Pharmacobio-Dynamics|April 1, 1981
Saframycin S, a new saframycin group antibioticY Mikami, K Yokoyama, H Tabeta, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1989
In-vitro activity of flomoxef, a new oxacephem group antibiotic, against Nocardia in comparison with other cephalosporinsK Yazawa, Y Mikami, J Uno, et al.Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|July 1, 1984
Leucinostatins, peptide mycotoxins produced by Paecilomyces lilacinus and their possible roles in fungal infectionY Mikami, K Fukushima, T Arai, et al.The Journal of Antibiotics|December 1, 1986
Isolation and structural elucidation of new saframycins Y3, Yd-1, Yd-2, Ad-1, Y2b and Y2b-dK Yazawa, K Takahashi, Y Mikami, et al.Japanese Journal of Cancer Research : Gann|October 1, 1986
Antitumor activity of new semisynthetic saframycin derivativesS Kaneda, C Hour-Young, K Yazawa, et al.Mycopathologia|December 1, 1989
Paecilotoxin production in clinical or terrestrial isolates of Paecilomyces lilacinus strainsY Mikami, K Yazawa, K Fukushima, et al.The Journal of Biological Chemistry|January 10, 1985
Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulaeY Mikami, K Takahashi, K Yazawa, et al.Pageof 141